UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Heart failure in Fabry disease revisited: application of current heart failure guidelines and recommendations

ESC Heart Failure, 2022-12, Vol.9 (6), p.4043-4052

2022

Volltextzugriff (PDF)

Anderson–Fabry Disease Homozygosity: Rare Case of Late-Onset Variant

Cardiogenetics, 2024-06, Vol.14 (2), p.74-83

2024

Volltextzugriff (PDF)

Characterization of early disease status in treatment-naive male paediatric patients with Fabry disease enrolled in a randomized clinical trial

PloS one, 2015-05, Vol.10 (5), p.e0124987-e0124987

2015

Volltextzugriff (PDF)

Anderson-Fabry disease: No histological signs of pathological accumulation in arterial and venous endothelium during pegunigalsidase alfa therapy

Kardiologia polska, 2021-12, Vol.79 (12), p.1385-1386

2021

Volltextzugriff (PDF)

Variations of the Saphenopopliteal Junction: An Ultrasonography Study in a Young Population, A Systematic Review and A Meta-Analysis

Angiology, 2024-07, Vol.75 (6), p.527-535

2024

Volltextzugriff (PDF)

Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were previously treated with agalsidase alfa: results from BRIDGE, a phase 3 open-label study

Orphanet journal of rare diseases, 2023-10, Vol.18 (1), p.1-332, Article 332

2023

Volltextzugriff (PDF)

Usefulness of Alcohol Septal Ablation in the Left Ventricular Outflow Tract Obstruction in Fabry Disease Cardiomyopathy

The American journal of cardiology, 2021-07, Vol.150, p.110-113

2021

Volltextzugriff (PDF)

Three-dimensional echocardiographic left ventricular strain analysis in Fabry disease: correlation with heart failure severity, myocardial scar, and impact on long-term prognosis

European heart journal cardiovascular imaging, 2023-11, Vol.24 (12), p.1629-1637

2023

Volltextzugriff (PDF)

Right Ventricular Involvement in Fabry Disease

Journal of the American Society of Echocardiography, 2008-11, Vol.21 (11), p.1265-1268

2008

Volltextzugriff (PDF)

Pitfalls of X‐chromosome inactivation testing in females with Fabry disease

American journal of medical genetics. Part A, 2022-07, Vol.188 (7), p.1979-1989

2022

Volltextzugriff (PDF)

LysoGb3 quantification facilitates phenotypic categorization of Fabry disease patients: Insights gained by a novel MS/MS method

Clinica chimica acta, 2024-07, Vol.561, p.119824, Article 119824

2024

Volltextzugriff (PDF)

Uric Acid as a Marker of Mortality and Morbidity in Fabry Disease

PloS one, 2016-11, Vol.11 (11), p.e0166290-e0166290

2016

Volltextzugriff (PDF)

Cerebrovascular Phenotype in Fabry Disease Patients Assessed by Ultrasound

Journal of ultrasound in medicine, 2023-10, Vol.42 (10), p.2315-2330

2023

Volltextzugriff (PDF)

Missed diagnosis of Fabry disease: should we screen patients with multiple sclerosis?

Neurological sciences, 2024-01, Vol.45 (1), p.231-239

2024

Volltextzugriff (PDF)

A rare bird of Czechia: Case of homozygous female Fabry disease patient

Molecular genetics and metabolism, 2020-02, Vol.129 (2), p.S50-S50

2020

Volltextzugriff (PDF)

Serum Bilirubin and Markers of Oxidative Stress and Inflammation in a Healthy Population and in Patients with Various Forms of Atherosclerosis

Antioxidants, 2022-10, Vol.11 (11), p.2118

2022

Volltextzugriff (PDF)

Heart Failure Caused by Misdiagnosed Subaortic Stenosis in Adulthood: Lesson for Daily Practice

The Annals of thoracic surgery, 2017-07, Vol.104 (1), p.e91-e91

2017

Volltextzugriff (PDF)

Assessment of Asymptomatic Severe Aortic Regurgitation by Doppler-Derived Echo Indices: Comparison with Magnetic Resonance Quantification

Journal of clinical medicine, 2021-12, Vol.11 (1), p.152

2021

Volltextzugriff (PDF)

Nationwide screening of Fabry disease in patients with hypertrophic cardiomyopathy in Czech Republic

ESC Heart Failure, 2022-12, Vol.9 (6), p.4160-4166

2022

Volltextzugriff (PDF)

Erectile Dysfunction in Young Myocardial Infarction Survivors: Evaluation, Follow Up

American journal of men's health, 2017-11, Vol.11 (6), p.1739-1744

2017

Volltextzugriff (PDF)

Detailed Phenotype of GLA Variants Identified by the Nationwide Neurological Screening of Stroke Patients in the Czech Republic

Journal of clinical medicine, 2021-08, Vol.10 (16), p.3543

2021

Volltextzugriff (PDF)

eP163 - Renal and secondary outcomes 1 year after switching from agalsidase alfa to pegunigalsidase alfa for Fabry disease (the BRIDGE study)

Molecular genetics and metabolism, 2021-04, Vol.132, p.S107-S108

2021

Volltextzugriff (PDF)

Renal and secondary outcomes 1 year after switching from agalsidase alfa to pegunigalsidase alfa for Fabry disease (the BRIDGE study)

Molecular genetics and metabolism, 2021-04, Vol.132, p.S107-S108

2021

Volltextzugriff (PDF)

Correction: Uric Acid as a Marker of Mortality and Morbidity in Fabry Disease

PloS one, 2017-01, Vol.12 (1), p.e0170881-e0170881

2017

Volltextzugriff (PDF)

1 – 25 von 69

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(68)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Heart failure in Fabry disease revisited: application of current heart failure guidelines and recommendations

Anderson–Fabry Disease Homozygosity: Rare Case of Late-Onset Variant

Characterization of early disease status in treatment-naive male paediatric patients with Fabry disease enrolled in a randomized clinical trial

Anderson-Fabry disease: No histological signs of pathological accumulation in arterial and venous endothelium during pegunigalsidase alfa therapy

Variations of the Saphenopopliteal Junction: An Ultrasonography Study in a Young Population, A Systematic Review and A Meta-Analysis

Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were previously treated with agalsidase alfa: results from BRIDGE, a phase 3 open-label study

Usefulness of Alcohol Septal Ablation in the Left Ventricular Outflow Tract Obstruction in Fabry Disease Cardiomyopathy

Three-dimensional echocardiographic left ventricular strain analysis in Fabry disease: correlation with heart failure severity, myocardial scar, and impact on long-term prognosis

Right Ventricular Involvement in Fabry Disease

Nationwide screening for Fabry disease in unselected stroke patients

Pitfalls of X‐chromosome inactivation testing in females with Fabry disease

LysoGb3 quantification facilitates phenotypic categorization of Fabry disease patients: Insights gained by a novel MS/MS method

Uric Acid as a Marker of Mortality and Morbidity in Fabry Disease

Cerebrovascular Phenotype in Fabry Disease Patients Assessed by Ultrasound

Missed diagnosis of Fabry disease: should we screen patients with multiple sclerosis?

A rare bird of Czechia: Case of homozygous female Fabry disease patient

Serum Bilirubin and Markers of Oxidative Stress and Inflammation in a Healthy Population and in Patients with Various Forms of Atherosclerosis

Heart Failure Caused by Misdiagnosed Subaortic Stenosis in Adulthood: Lesson for Daily Practice

Assessment of Asymptomatic Severe Aortic Regurgitation by Doppler-Derived Echo Indices: Comparison with Magnetic Resonance Quantification

Nationwide screening of Fabry disease in patients with hypertrophic cardiomyopathy in Czech Republic

Erectile Dysfunction in Young Myocardial Infarction Survivors: Evaluation, Follow Up

Detailed Phenotype of GLA Variants Identified by the Nationwide Neurological Screening of Stroke Patients in the Czech Republic

eP163 - Renal and secondary outcomes 1 year after switching from agalsidase alfa to pegunigalsidase alfa for Fabry disease (the BRIDGE study)

Renal and secondary outcomes 1 year after switching from agalsidase alfa to pegunigalsidase alfa for Fabry disease (the BRIDGE study)

Correction: Uric Acid as a Marker of Mortality and Morbidity in Fabry Disease

Suchergebnisse filtern